Belimumab: A Review in Systemic Lupus Erythematosus.

J Cortés, JL Andreu, J Calvo, AM García-Aparicio, CG Coronell, S Díaz-Cerezo, None, Evaluation of Use of Belimumab In Clinical Practice Settings (Observe Study) In Spain: Health Resource Utilization and Labour Absenteeism. Value in Health. ,vol. 17, ,(2014) , 10.1016/J.JVAL.2014.08.1703

K. Athanasakis, E. Karampli, M. Ollandezos, M. Igoumenidis, P. Karabela, D. Psomali, J. Kyriopoulos, Belimumab for the Treatment of Systemic Lupus Erythematosus (Sle) In Greece: A Cost-Effectiveness and Cost-Utility Analysis Value in Health. ,vol. 17, ,(2014) , 10.1016/J.JVAL.2014.08.1694

Kevin P. Baker, Bryan M. Edwards, Sarah H. Main, Gil H. Choi, Ruth E. Wager, Wendy G. Halpern, Patrick B. Lappin, Todd Riccobene, Donara Abramian, Les Sekut, Bonnie Sturm, Carol Poortman, Ralph R. Minter, Claire L. Dobson, Elizabeth Williams, Sara Carmen, Rodger Smith, Viktor Roschke, David M. Hilbert, Tristan J. Vaughan, Vivian R. Albert, Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Arthritis & Rheumatism. ,vol. 48, pp. 3253- 3265 ,(2003) , 10.1002/ART.11299

L.A. Vallejo-Aparicio, S. Díaz-Cerezo, J. Parrondo, A.M. García-Aparicio, Cost-Effectiveness Analysis of Belimumab In the Treatment of Adult Systemic Lupus Erythematosus (Sle) Patients With Positive Biomarkers In Spain. Value in Health. ,vol. 17, ,(2014) , 10.1016/J.JVAL.2014.08.1683

Celeste B. Burness, Paul L. McCormack, Belimumab Drugs. ,vol. 71, pp. 2435- 2444 ,(2011) , 10.2165/11208440-000000000-00000

W. WINN CHATHAM, DANIEL J. WALLACE, WILLIAM STOHL, KEVIN M. LATINIS, SUSAN MANZI, W. JOSEPH McCUNE, DANA TEGZOVÁ, JAMES D. McKAY, HILARIO E. AVILA-ARMENGOL, TAMMY O. UTSET, Z. JOHN ZHONG, DOUGLAS R. HOUGH, WILLIAM W. FREIMUTH, THI-SAU MIGONE, Effect of Belimumab on Vaccine Antigen Antibodies to Influenza, Pneumococcal, and Tetanus Vaccines in Patients with Systemic Lupus Erythematosus in the BLISS-76 Trial The Journal of Rheumatology. ,vol. 39, pp. 1632- 1640 ,(2012) , 10.3899/JRHEUM.111587

Daniel J. Wallace, William Stohl, Richard A. Furie, Jeffrey R. Lisse, James D. McKay, Joan T. Merrill, Michelle A. Petri, Ellen M. Ginzler, W. Winn Chatham, W. Joseph McCune, Vivian Fernandez, Marc R. Chevrier, Z. John Zhong, William W. Freimuth, A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Belimumab in Patients With Active Systemic Lupus Erythematosus Arthritis Care and Research. ,vol. 61, pp. 1168- 1178 ,(2009) , 10.1002/ART.24699

Francesca Pierotti, Ilaria Palla, Maarten Treur, Lara Pippo, Giuseppe Turchetti, Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis PLOS ONE. ,vol. 10, pp. 1- 18 ,(2015) , 10.1371/JOURNAL.PONE.0140843

Vibeke Strand, Roger A Levy, Ricard Cervera, Michelle A Petri, Helen Birch, William W Freimuth, Z John Zhong, Ann E Clarke, , Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials Annals of the Rheumatic Diseases. ,vol. 73, pp. 838- 844 ,(2014) , 10.1136/ANNRHEUMDIS-2012-202865

Ronald F Van Vollenhoven, Michelle A Petri, Ricard Cervera, David A Roth, Beulah N Ji, Christi S Kleoudis, Z John Zhong, William Freimuth, None, Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response Annals of the Rheumatic Diseases. ,vol. 71, pp. 1343- 1349 ,(2012) , 10.1136/ANNRHEUMDIS-2011-200937